By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Flexion Therapeutics 

300 TradeCenter
Suite 2460
Woburn  Massachusetts  01801  U.S.A.
Phone: 781-897-9977 Fax: 781-897-9970



Company News
Flexion (FLXN) To Present At Stifel 2015 Healthcare Conference 11/16/2015 10:56:14 AM
Flexion (FLXN) Reports Third-Quarter 2015 Financial Results 11/10/2015 9:59:25 AM
Flexion (FLXN) To Report Third-Quarter 2015 Financial Results On November 9, 2015 11/2/2015 12:42:40 PM
Flexion (FLXN) Tanks as Lead Drug Flunks Pivotal Phase IIb Clinical Trial 9/9/2015 6:06:32 AM
Flexion (FLXN) Granted Fast Track Status By The FDA For FX006 For Treatment Of Osteoarthritis Of The Knee 9/2/2015 7:04:47 AM
Flexion (FLXN) Reports Second-Quarter 2015 Financial Results 8/7/2015 8:21:04 AM
Flexion (FLXN) Expands Supply Capacity For FX006 By Entering Into Agreement With Patheon (PTI.TO) 8/5/2015 7:12:22 AM
Flexion (FLXN) Secures $30 Million In Debt Financing 8/5/2015 7:10:22 AM
Flexion (FLXN) Completes Enrollment In Phase III Clinical Trial With Lead Compound FX006 In Patients With Osteoarthritis Of The Knee 7/30/2015 6:54:53 AM
Flexion (FLXN)' Final FX006 Data From Completed Phase IIb Dose-Ranging Trial Published In Journal Of Bone And Joint Surgery 6/4/2015 7:26:15 AM